Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy on Progression Free Overall Survival of a Dose-Adjusted Regimen in Frail Adult Patients With Acute Lymphoblastic Leukemia

NCT07258043 is registered in ClinicalTrials.gov with Hospital General de Mexico as lead sponsor.

NCT NCT07258043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07258043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy on Progression Free Overall Survival of a Dose-Adjusted Regimen in Frail Adult Patients With Acute Lymphoblastic Leukemia
Lead sponsor
Hospital General de Mexico
Phase
Observational
Overall status
Recruiting
Start date
July 23, 2025
Completion date
July 26, 2026
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphobkastic leukemia, leukemia, overall survival